Pfizer, BioNTech propose expanding COVID-19 vaccine trial to 44,000 volunteers
Drugmakers racing to develop a safe and effective coronavirus vaccine pledged in July to ensure their larger clinical trials would include diverse sets of volunteers. "Diversity in clinical trials is a priority for Pfizer and is critical given that COVID-19 disproportionately impacts communities

Full story is loading. Click here if it doesn't...